(ENTA) Enanta Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Enanta Pharmaceuticals | (ENTA) share price targets
Complete technical analysis of Enanta Pharmaceuticals (ENTA) by charts plus indicators, forecast predictions and share price targets for Enanta Pharmaceuticals (ENTA)
Enanta Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-08 View latest technical analysis
10 day averaged volume of Enanta Pharmaceuticals is 99870
Date | Daily Closing Price | Open | High | Low | Volume |
08 Fri Nov 2024 | 11.07 | 11.27 | 11.31 | 11.00 | 0.64 times |
07 Thu Nov 2024 | 11.35 | 11.56 | 11.57 | 11.35 | 0.627 times |
06 Wed Nov 2024 | 11.52 | 11.80 | 11.83 | 11.08 | 1.45 times |
05 Tue Nov 2024 | 11.26 | 11.12 | 11.40 | 10.99 | 0.748 times |
04 Mon Nov 2024 | 11.11 | 10.92 | 11.35 | 10.84 | 0.899 times |
01 Fri Nov 2024 | 10.95 | 11.32 | 11.39 | 10.93 | 1.001 times |
31 Thu Oct 2024 | 11.25 | 11.51 | 11.57 | 10.71 | 0.893 times |
30 Wed Oct 2024 | 11.49 | 11.49 | 11.68 | 11.28 | 1.195 times |
29 Tue Oct 2024 | 11.50 | 11.51 | 11.58 | 11.26 | 1.144 times |
28 Mon Oct 2024 | 11.58 | 11.78 | 12.09 | 11.52 | 0.938 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 11.2, but if it comes above 11.2, then a intra day buy could be more profitable.
If you take a sell trade below 11.2, then use 11.2 as stoploss and 10.4 as target. However if you take a buy trade in stock , then use 11.2 as stoploss and 11.76 as target.
Share price targets for Enanta Pharmaceuticals (ENTA)
Target Type | Value |
Downside Target | 9.90 |
Downside Target | 10.40 |
Downside Target | 10.71 |
Upside Target | 11.42 |
Upside Target | 12.09 |
Upside Target | 12.47 |
Upside Target | 12.70 |
Upside Target | 13.24 |
Upside Target | 13.37 |
Upside Target | 15.11 |
Upside Target | 17.24 |
Intraday share price targets for Enanta Pharmaceuticals (ENTA)
Target Type | Value |
Downside Intraday Target | 10.66 |
Downside Intraday Target | 10.26 |
Upside Intraday Target | 11.65 |
Upside Intraday Target | 12.24 |
Upside Intraday Target | 11.25 |
Weekly technical analysis of Enanta Pharmaceuticals (ENTA)
Date | Weekly Closing Price | Open | High | Low | Volume |
08 Fri Nov 2024 | 11.07 | 10.92 | 11.83 | 10.84 | 0.844 times |
01 Fri Nov 2024 | 10.95 | 11.78 | 12.09 | 10.71 | 0.673 times |
25 Fri Oct 2024 | 11.68 | 12.59 | 13.37 | 11.64 | 1.295 times |
18 Fri Oct 2024 | 12.63 | 11.04 | 12.70 | 10.96 | 0.661 times |
11 Fri Oct 2024 | 11.04 | 11.45 | 11.80 | 10.40 | 0.704 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Enanta Pharmaceuticals (ENTA)
Date | Monthly Closing Price | Open | High | Low | Volume |
08 Fri Nov 2024 | 11.07 | 11.32 | 11.83 | 10.84 | 0.145 times |
31 Thu Oct 2024 | 11.25 | 10.56 | 13.37 | 9.98 | 1.058 times |
30 Mon Sep 2024 | 10.36 | 12.87 | 13.24 | 9.90 | 0.979 times |
30 Fri Aug 2024 | 12.88 | 14.86 | 15.11 | 11.42 | 0.92 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Enanta Pharmaceuticals (ENTA)
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Enanta Pharmaceuticals in short term and the sell signal is strong.
Enanta Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Enanta Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.33 and Enanta Pharmaceuticals (ENTA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Enanta Pharmaceuticals (ENTA) stock. Volume based technical analysis of Enanta Pharmaceuticals (ENTA) stock is negative.
Enanta Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Enanta Pharmaceuticals in short term and the sell signal is strong.
Enanta Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Enanta Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.33 and Enanta Pharmaceuticals (ENTA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Enanta Pharmaceuticals (ENTA) stock. Volume based technical analysis of Enanta Pharmaceuticals (ENTA) stock is negative.
Enanta Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.